Respiratory drug market dynamics

@article{Oversteegen2007RespiratoryDM,
  title={Respiratory drug market dynamics},
  author={Lisette Oversteegen and Holger Rovini and Mark J. Belsey},
  journal={Nature Reviews Drug Discovery},
  year={2007},
  volume={6},
  pages={695-696}
}
The respiratory drug market is dominated by just two indications: asthma and chronic obstructive pulmonary disease (COPD). Although these diseases are treated with the same drugs, they differ significantly in their underlying aetiology. Both are characterized by lung inflammation; however, patients with asthma suffer largely from reversible airflow obstruction, whereas patients with COPD experience a continuous decline in lung function as their disease progresses. Datamonitor estimates that… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-5 of 5 references

Prevalence of treated asthma and its management in general practice in England and Wales , 1994 – 1998

  • J. Hoare, M. Bruce, A. Majeed
  • Health Stat . Q .
  • 2003

The seven major markets comprise of the five major European markets (France, Germany, Italy, Spain and the UK), Japan and the US

  • D. M. Fleming, R. Sunderland, K. W. Cross, A. M. Ross
  • Thorax 55,
  • 2000

Early detection of COPD : a case finding study in general practice

  • J. Vandevoorde
  • Respir . Med .

Similar Papers

Loading similar papers…